Intérêts de la stimulation dopaminergique continue par Duodopa® dans la maladie de Parkinson évoluée : efficacité et tolérance

Duodopa® can be considered as a new treatment strategy providing significant improvements in motor fluctuations, dyskinesia and severe axial signs. These results were demonstrated in very advanced PD patients, who had been excluded from previous studies, with cognitive disorders and for some of them dopaminergic psychosis well controlled by medications.